Literature DB >> 11526231

Phospholamban domain IB forms an interaction site with the loop between transmembrane helices M6 and M7 of sarco(endo)plasmic reticulum Ca2+ ATPases.

M Asahi1, N M Green, K Kurzydlowski, M Tada, D H MacLennan.   

Abstract

Transmembrane helix M6 of the sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) has been shown to form a site of interaction with phospholamban (PLN). Site-directed mutagenesis was carried out in the cytoplasmic loop (L67) between M6 and M7 in SERCA1a to detect other SERCA-PLN binding sites. Mutants N810A, D813A, and R822A had diminished ability to interact functionally with PLN, but only D813A and R822A had reduced physical interaction with PLN. PLN mutants R25A, Q26A, N27A, L28A, Q29A, and N30A had enhanced physical interaction with wild-type (wt) SERCA1a, but physical interaction of these PLN mutants with SERCA1a mutants D813A and R822A was reduced about 2.5 fold (range 1.44-2.82). Exceptions were the interactions of PLN N27A and N30A with SERCA1a D813A, which were reduced by 7.3- and 5.8-fold, respectively. A superinhibitory PLN deletion mutant, PLNDelta21-29, had strong physical interactions with SERCA1a and with SERCA1a mutant D813A. Physical interactions with SERCA1a and mutant D813A were sharply diminished, however, for the PLN deletion mutant, PLNDelta21-30, lacking PLN N30. Physical interactions between SERCA1a and a PLN-cytochrome b(5) chimera containing PLN residues 1-29 were much stronger than those between a PLN-cytochrome b(5) chimera containing PLN residues 1-21 and lacking N27. These results suggest that a SERCA1-PLN interaction site occurs between L67 of SERCA1a and domain IB of PLN, which involves SERCA1a D813 and PLN N27 and N30.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526231      PMCID: PMC56915          DOI: 10.1073/pnas.181348298

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Modeling a dehalogenase fold into the 8-A density map for Ca(2+)-ATPase defines a new domain structure.

Authors:  D L Stokes; N M Green
Journal:  Biophys J       Date:  2000-04       Impact factor: 4.033

2.  Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 A resolution.

Authors:  C Toyoshima; M Nakasako; H Nomura; H Ogawa
Journal:  Nature       Date:  2000-06-08       Impact factor: 49.962

3.  Transmembrane helix M6 in sarco(endo)plasmic reticulum Ca(2+)-ATPase forms a functional interaction site with phospholamban. Evidence for physical interactions at other sites.

Authors:  M Asahi; Y Kimura; K Kurzydlowski; M Tada; D H MacLennan
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

Review 4.  Phospholamban: protein structure, mechanism of action, and role in cardiac function.

Authors:  H K Simmerman; L R Jones
Journal:  Physiol Rev       Date:  1998-10       Impact factor: 37.312

Review 5.  Cryoelectron microscopy of the calcium pump from sarcoplasmic reticulum: two crystal forms reveal two different conformations.

Authors:  D L Stokes; P Zhang; C Toyoshima; K Yonekura; H Ogawa; M R Lewis; D Shi
Journal:  Acta Physiol Scand Suppl       Date:  1998-08

6.  Structure of the Ca2+ pump of sarcoplasmic reticulum: a view along the lipid bilayer at 9-A resolution.

Authors:  H Ogawa; D L Stokes; H Sasabe; C Toyoshima
Journal:  Biophys J       Date:  1998-07       Impact factor: 4.033

7.  Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo.

Authors:  J Zhai; A G Schmidt; B D Hoit; Y Kimura; D H MacLennan; E G Kranias
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

8.  Physical interactions between phospholamban and sarco(endo)plasmic reticulum Ca2+-ATPases are dissociated by elevated Ca2+, but not by phospholamban phosphorylation, vanadate, or thapsigargin, and are enhanced by ATP.

Authors:  M Asahi; E McKenna; K Kurzydlowski; M Tada; D H MacLennan
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

9.  The transgenic expression of highly inhibitory monomeric forms of phospholamban in mouse heart impairs cardiac contractility.

Authors:  E Zvaritch; P H Backx; F Jirik; Y Kimura; S de Leon; A G Schmidt; B D Hoit; J W Lester; E G Kranias; D H MacLennan
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

10.  Structure of the 1-36 amino-terminal fragment of human phospholamban by nuclear magnetic resonance and modeling of the phospholamban pentamer.

Authors:  P Pollesello; A Annila; M Ovaska
Journal:  Biophys J       Date:  1999-04       Impact factor: 4.033

View more
  7 in total

1.  Phospholamban phosphorylation, mutation, and structural dynamics: a biophysical approach to understanding and treating cardiomyopathy.

Authors:  Naa-Adjeley D Ablorh; David D Thomas
Journal:  Biophys Rev       Date:  2015-01-21

Review 2.  The Ca2+ pumps of the endoplasmic reticulum and Golgi apparatus.

Authors:  Ilse Vandecaetsbeek; Peter Vangheluwe; Luc Raeymaekers; Frank Wuytack; Jo Vanoevelen
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-05-01       Impact factor: 10.005

Review 3.  Phospholamban and sarcolipin: Are they functionally redundant or distinct regulators of the Sarco(Endo)Plasmic Reticulum Calcium ATPase?

Authors:  Sana A Shaikh; Sanjaya K Sahoo; Muthu Periasamy
Journal:  J Mol Cell Cardiol       Date:  2015-12-29       Impact factor: 5.000

4.  Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase.

Authors:  Chikashi Toyoshima; Michio Asahi; Yuji Sugita; Reena Khanna; Takeo Tsuda; David H MacLennan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-13       Impact factor: 11.205

5.  SERCA2a-phospholamban interaction monitored by an interposed circularly permutated green fluorescent protein.

Authors:  Maren E Arnold; Wolfgang R Dostmann; Jody Martin; Michael J Previs; Bradley Palmer; Martin LeWinter; Markus Meyer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-04-16       Impact factor: 5.125

Review 6.  Na+/Ca2+ exchange and Na+/K+-ATPase in the heart.

Authors:  Michael J Shattock; Michela Ottolia; Donald M Bers; Mordecai P Blaustein; Andrii Boguslavskyi; Julie Bossuyt; John H B Bridge; Ye Chen-Izu; Colleen E Clancy; Andrew Edwards; Joshua Goldhaber; Jack Kaplan; Jerry B Lingrel; Davor Pavlovic; Kenneth Philipson; Karin R Sipido; Zi-Jian Xie
Journal:  J Physiol       Date:  2015-03-15       Impact factor: 5.182

Review 7.  Lessons from the Endoplasmic Reticulum Ca2+ Transporters-A Cancer Connection.

Authors:  Xingjian Zhai; Andra Mihaela Sterea; Yassine El Hiani
Journal:  Cells       Date:  2020-06-24       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.